Resistance artery mechanics and composition in angiotensin II-infused mice: Effects of cyclooxygenase-1 inhibition

European Heart Journal

Volumn 33, Issue 17, 2012, Pages 2225-2234

  Virdis, Agostino ^a   Colucci, Rocchina ^a   Neves, Mario Fritsch ^b   Rugani, Ilaria ^a   Aydinoglu, Fatma ^a   Fornai, Matteo ^a   Ippolito, Chiara ^a   Antonioli, Luca ^a   Duranti, Emiliano ^a   Solini, Anna ^a   Bernardini, Nunzia ^a   Blandizzi, Corrado ^a   Taddei, Stefano ^a  

^a UNIVERSITY OF PISA   (Italy)

^b STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Angiotensin II; Cyclooxygenase; Extracellular matrix; Microcirculation; Vascular mechanics

Indexed keywords

2 FLUOROETHYL N,N DIMETHYLCARBAMATE; 5 (4 CHLOROPHENYL) 1 (4 METHOXYPHENYL) 3 TRIFLUOROMETHYL 1H PYRAZOLE; 6 OXOPROSTAGLANDIN F1 ALPHA; 7 [3 [(4 PHENYLSEMICARBAZIDO)METHYL] 7 OXABICYCLO[2.2.1]HEPT 2 YL] 5 HEPTENOIC ACID; ANGIOTENSIN II; COLLAGEN; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; ELASTIN; FIBRONECTIN; PROCOLLAGEN; PROCOLLAGEN 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTERY RESISTANCE; ARTICLE; BLOOD VESSEL WALL; BODY WEIGHT; COLLAGEN SYNTHESIS; CONTROLLED STUDY; ELASTICITY; ENZYME ACTIVATION; ENZYME INHIBITION; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; HYPERTROPHY; MALE; MESENTERIC ARTERY; MOLECULAR MECHANICS; MORPHOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RIGIDITY; SMOOTH MUSCLE FIBER; SYSTOLIC BLOOD PRESSURE; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING;

6-KETOPROSTAGLANDIN F1 ALPHA; ANALYSIS OF VARIANCE; ANGIOTENSIN II; ANIMALS; BIOMECHANICS; BLOOD PRESSURE; CELLS, CULTURED; COLLAGEN TYPE I; CORONARY VESSELS; CYCLOOXYGENASE 1; CYCLOOXYGENASE INHIBITORS; DINOPROST; ELASTIN; FIBRONECTINS; HUMANS; HYDRAZINES; IMMUNOHISTOCHEMISTRY; MALE; MESENTERIC ARTERIES; MICE; MICE, KNOCKOUT; PYRAZOLES; VASCULAR RESISTANCE;

EID: 84866108905     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehr138     Document Type: Article

References (23)

1. Touyz RM. Molecular and cellular mechanisms in vascular injury in hypertension: role of angiotensin II. Curr Opin Nephrol Hypertens 2005;14:125-131. (Pubitemid 40396865)
2. Schiffrin EL. Remodeling of resistance arteries in essential hypertension and effects of antihypertensive treatment. Am J Hypertens 2004;17:1192-1200. (Pubitemid 40029420)
3. Intengan HD, Schiffrin EL. Structure and mechanical properties of resistance arteries in hypertension: role of adhesion molecules and extracellular matrix determinants. Hypertension 2000;36:312-318.
4. Neves MF, Virdis A, Schiffrin EL. Resistance artery mechanics and composition in angiotensin II-infused rats: effects of aldosterone antagonism. J Hypertens 2003;21: 189-198. (Pubitemid 36143524)
5. Neves MF, Endemann D, Amiri F, Virdis A, Pu Q, Rozen R, Schiffrin EL. Small artery mechanics in hyperhomocysteinemic mice: effects of angiotensin II. J Hypertens 2004;22:959-966. (Pubitemid 38680471)
6. Brassard P, Amiri F, Schiffrin EL. Combined angiotensin II type 1 and type 2 receptor blockade on vascular remodeling and matrix metalloproteinases in resistance arteries. Hypertension 2005;46:598-606. (Pubitemid 41376842)
7. Pratico D, Tillmann C, Zhang ZB, Li H, FitzGerald GA. Acceleration of atherogen-esis by COX-1-dependent prostanoid formation in low density lipoprotein receptor knockout mice. Proc Natl Acad Sci U S A 2001;98:3358-3363. (Pubitemid 32220850)
8. Cayatte AJ, Du Y, Oliver-Krasinski J, Lavielle G, Verbeuren TJ, Cohen RA. The thromboxane receptor antagonist S18886 but not aspirin inhibits atherogenesis in apo E-deficient mice: evidence that eicosanoids other than thromboxane contribute to atherosclerosis. Arterioscler Thromb Vasc Biol 2000;20:1724-1728. (Pubitemid 30470586)
9. Virdis A, Colucci R, Fornai M, Duranti E, Giannarelli C, Bernardini N, Segnani C, Ippolito C, Antonioli L, Blandizzi C, Taddei S, Salvetti A, Del Tacca M. Cyclooxygenase-1 is involved in endothelial dysfunction of mesenteric small arteries from angiotensin II-infused mice. Hypertension 2007;49:679-686.
10. Li W, Ji ZL, Zhuo GC, Xu RJ, Wang J, Jiang HR. Effects of a selective cyclooxygenase-1 inhibitor in SKOV-3 ovarian carcinoma xenograft-bearing mice. Med Oncol 2009;27:98-104.
11. Shen CL, Yeh JK, Wang X. Short-term supplementation of COX-2 inhibitor suppresses bone turnover in gonad-intact middle-aged male rats. J Bone Miner Metab 2006;24:461-466. (Pubitemid 44663418)
12. Tang M, Cyrus T, Yao Y, Vocun L, Pratico D. Involvement of thromboxane receptor in the proatherogenic effect of isoprostane F2alpha-III: evidence from apolipo-protein E- and LDL receptor-deficient mice. Circulation 2005;112:2867-2874. (Pubitemid 41641682)
13. Virdis A, Colucci R, Versari D, Ghisu N, Fornai M, Antonioli L, Duranti E, Daghini E, Giannarelli C, Blandizzi C, Taddei S, Del Tacca M. Atorvastatin prevents endothelial dysfunction in mesenteric arteries from spontaneously hypertensive rats: role of cyclooxygenase 2-derived contracting prostanoids. Hypertension 2009;53:1008-1016.
14. Touyz RM, He G, El Mabrouk M, Schiffrin EL. p38 Map kinase regulates vascular smooth muscle cell collagen synthesis by angiotensin II in SHR but not in WKY. Hypertension 2001;37:574-580. (Pubitemid 32199030)
15. Zhang M, Dong Y, Xu J, Xie Z, Wu Y, Song P, Guzman M, Wu J, Zou MH. Throm-boxane receptor activates the AMP-activated protein kinase in vascular smooth muscle cells via hydrogen peroxide. Circ Res 2008;102:328-337. (Pubitemid 351271653)
16. Gluais P, Lonchampt M, Morrow JD, Vanhoutte PM, Feletou M. Acetylcholine-induced endothelium-dependent contractions in the SHR aorta: the Janus face of prostacyclin. Br J Pharmacol 2005;146:834-845. (Pubitemid 41622250)
17. Alvarez Y, Briones AM, Balfagon G, Alonso MJ, Salaices M. Hypertension increases the participation of vasoconstrictor prostanoids from cyclooxygenase-2 in phenylephrine responses. J Hypertens 2005;23:767-777. (Pubitemid 40523275)
18. Welch WJ, Patel K, Modlinger P, Mendonca M, Kawada N, Dennehy K, Aslam S, Wilcox CS. Roles of vasoconstrictor prostaglandins, COX-1 and -2, and AT1, AT2, and TP receptors in a rat model of early 2K, 1C hypertension. Am J Physiol Heart Circ Physiol 2007;293:H2644-H2649. (Pubitemid 350106484)
19. Vanhoutte PM, Tang EH. Endothelium-dependent contractions: when a good guy turns bad! J Physiol 2008;586:5295-5304.
20. Intengan HD, Thibault G, Li JS, Schiffrin EL. Resistance artery mechanics, structure, and extracellular components in spontaneously hypertensive rats: effects of angiotensin receptor antagonism and converting enzyme inhibition. Circulation 1999;100:2267-2275.
21. Kato H, Suzuki H, Tajima S, Ogata Y, Tominaga T, Sato A, Saruta T. Angiotensin II stimulates collagen synthesis in cultured vascular smooth muscle cells. J Hypertens 1991;9:17-22.
22. Paravicini TM, Touyz RM. Redox signaling in hypertension. Cardiovasc Res 2006;71: 247-258.
23. Virdis A, Neves MF, Amiri F, Touyz RM, Schiffrin EL. Role of NAD(P)H oxidase on vascular alterations in angiotensin II-infused mice. J Hypertens 2004;22:535-542. (Pubitemid 38368487)